Carregant...
Carregant...

Vés al contingut (premeu Retorn)

Nanotransformation of vancomycin for overcoming Gram-negative bacteria intrinsic resistance

Autor
Hoyo, J.; Ivanova, K.; Tzanov, T.
Tipus d'activitat
Presentació treball a congrés
Nom de l'edició
253rd American Chemical Society, National Meeting & Exposition, Advanced Materials, Technologies, Systems & Processes
Any de l'edició
2017
Data de presentació
2017-04-02
Llibre d'actes
253rd American Chemical Society National Meeting & Exposition : Advanced Materials, Technologies, Systems & Processes, April 2-6, 2017 San Francisco, CA
Resum
Bacterial infections caused by drug resistant strains are one of the world’s public health challenges and the development of alternative strategies is extensively being searched. Vancomycin is a glycopeptide antibiotic largely used for treatment of infections caused by Gram­positive bacteria. However, it has little effect against Gram­negative bacteria due to its inability to penetrate their outer membrane, impermeable to such large molecules. The assemblies of molecules at nanometer dimensi...
Grup de recerca
GBMI - Grup de Biotecnologia Molecular i Industrial

Participants